Australia Bans Replica Versions Of Popular Weight-Loss Drugs From Novo Nordisk, Eli Lilly On Safety Concerns [Yahoo! Finance]
Eli Lilly and Company (LLY)
Last eli lilly and company earnings: 4/23 06:25 am
Check Earnings Report
US:NYSE Investor Relations:
investor.lilly.com
Company Research
Source: Yahoo! Finance
Recently, the Chinese regulatory authority approved Eli Lilly's diabetes drug, tirzepatide Health Minister Mark Butler emphasized that these unregulated copies have not undergone rigorous testing, leading to potential patient risks. Related: The Ozempic Diet: Nestle Launches $5 Pizza For Weight Loss Drug Users Demand for Ozempic and Mounjaro has surged due to their effectiveness in weight loss. However, the popularity of these medications has led to shortages, prompting some patients to turn to compounded alternatives. Compounded drugs are custom-made versions based on the same ingredients as branded drugs. While often cheaper, they lack clinical evaluation by regulators for safety, quality, or efficacy. Butler noted a rise in reports of adverse events linked to these GLP-1 copies, including a serious incident that resulted in hospitalization. Reuters noted that to protect public health, Butler announced new regulations to remove GLP-1 receptor agonists, such as those being
Show less
Read more
Impact Snapshot
Event Time:
LLY
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
LLY alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
LLY alerts
High impacting Eli Lilly and Company news events
Weekly update
A roundup of the hottest topics
LLY
News
- Eli Lilly unveils new manufacturing plant for GLP-1 pens [Yahoo! Finance Canada]Yahoo! Finance Canada
- Pre-diabetes rates increase amidst a renaissance for type 2 diabetes research [Yahoo! Finance]Yahoo! Finance
- Biologics Market to Surpass USD 1125.55 Billion by 2031 | SkyQuest [Yahoo! Finance]Yahoo! Finance
- Eli Lilly doubles investment to $2 billion in Concord pharma facility ahead of opening [Yahoo! Finance]Yahoo! Finance
- Aktis Oncology Expands its Board of Directors with Appointment of Nuclear Medicine Expert Ken Herrmann, MD, MBA [Yahoo! Finance]Yahoo! Finance
LLY
Earnings
- 4/30/24 - Beat
LLY
Sec Filings
- 6/14/24 - Form 144
- 6/11/24 - Form 4
- 6/10/24 - Form 4
- LLY's page on the SEC website